V Square Quantitative Management LLC Raises Holdings in Cigna Group $CI

V Square Quantitative Management LLC lifted its stake in Cigna Group (NYSE:CI) by 2.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,480 shares of the health services provider’s stock after buying an additional 124 shares during the quarter. V Square Quantitative Management LLC’s holdings in Cigna Group were worth $2,142,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD boosted its position in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after purchasing an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in Cigna Group by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after purchasing an additional 98,715 shares in the last quarter. Dodge & Cox boosted its position in Cigna Group by 1.3% during the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after purchasing an additional 117,125 shares in the last quarter. GQG Partners LLC boosted its position in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Finally, Parnassus Investments LLC boosted its position in Cigna Group by 3.1% during the first quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider’s stock worth $949,357,000 after purchasing an additional 86,602 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

NYSE CI opened at $286.04 on Monday. The company has a market cap of $76.35 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 0.84 and a beta of 0.48. The stock’s 50 day simple moving average is $292.71 and its 200-day simple moving average is $310.49. Cigna Group has a 1-year low of $256.89 and a 1-year high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter last year, the firm earned $6.72 earnings per share. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Truist Financial set a $375.00 price target on Cigna Group in a research report on Tuesday, September 2nd. Barclays increased their price target on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Guggenheim reiterated a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.